SAN FRANCISCO, Calif-Seven researchers from the University of California at San Francisco, along with a variety of international physicians and researchers specializing in AIDS, liver disease, substance abuse, and health policy, have written an article urging the treatment of hepatitis C patients who are also drug users.
To date, the National Institute of Health (NIH) recommends that patients who are using illicit drugs be denied treatment until they have stopped using for six months.
The authors, on the other hand, recommend that patients who are ill with hepatitis C can be treated for their disease while being educated on how to prevent possible future infection.
Their education plan includes several suggestions on how to prevent using used needles. If they are using illicit drugs that require needles and are unable to treat their addiction, they should enroll in a clean needle program, now available in more than 120 American cities. They should also consider buying new needles from pharmacies and never share their needles with other users.
The article is based on statistics that majority of hepatitis C infections in the US come from drug users who share needles.
The liver disease, caused by a virus, can be treated and removed from the body in two out of three patients. Most people with the disease feel well and do not have any symptoms of the disease until their livers are already severely damaged.
Information from www.hivandhepatitis.com, www.cdc.gov<I/>
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
Unlocking the Power of AI in Hospital Infection Prevention: A Sustainable Approach to HAIs
April 11th 2024Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.
Deeds to Reality: A Journey of Immigration and Obstacles With Carole W. Kamangu, MPH, RN, CIC
April 9th 2024Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)
How to Be Confident in Your Disinfection: UV-C Disinfection, Dosimeter Cards, and Audits
April 4th 2024Recent research in the American Journal of Infection Control reveals gaps in routine hospital disinfection, highlighting the need for UV-C audits. Learn how to validate UV-C dosages effectively and conduct successful audits.